Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders
申请人:Cephalon, Inc.
公开号:US20140350011A1
公开(公告)日:2014-11-27
This application relates to compounds of the Formula I
as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.